Keyvan Mahboubi

1.6k citations
22 papers · 1.3k indexed · 1 hit paper · h-index 15
Topics
Cytokine Signaling Pathways and Interactions (8 papers)Inflammatory mediators and NSAID effects (7 papers)Estrogen and related hormone effects (4 papers)

In The Last Decade

Keyvan Mahboubi

22 papers receiving 1.3k citations

Hit Papers

Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via th...20002026200820172000100200300400500

Peers

Keyvan Mahboubi
Comparison fields: 5 of 93
  • Molecular Biology 700
  • Immunology 331
  • Oncology 284
  • Cardiology and Cardiovascular Medicine 205
  • Cancer Research 173
Replace Toshimitsu Suhara with:
Toshimitsu Suhara Japan
Reeni B. Hildebrand Netherlands
Ruud Out Netherlands
Jaap Twisk Netherlands
Jerzy‐Roch Nofer Germany
Qunhua Huang United States
D.D. Soderman United States
Nancy Lewis Baenziger United States
Sabine Müller‐Brüsselbach Germany
Keyvan Mahboubi relative to Toshimitsu Suhara Japan Toshimitsu Suhara's profile →
Citations per field
00.5×5.5×
Toshimitsu Suhara · 1×
Citations per year

Countries citing papers authored by Keyvan Mahboubi

Since Specialization
Citations

This map shows the geographic impact of Keyvan Mahboubi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyvan Mahboubi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyvan Mahboubi more than expected).

Fields of papers citing papers by Keyvan Mahboubi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyvan Mahboubi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyvan Mahboubi. The network helps show where Keyvan Mahboubi may publish in the future.

Co-authorship network of co-authors of Keyvan Mahboubi

This figure shows the co-authorship network connecting the top 25 collaborators of Keyvan Mahboubi. A scholar is included among the top collaborators of Keyvan Mahboubi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyvan Mahboubi. Keyvan Mahboubi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 29
2 39
3 55
4 67
5 22
6 40
7 1
8 77
9 18
10 31
11 99
12
Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathwaybreakdown →
542
13 67
14 3
15 1
16 8
17
Production of PGE2 and 15-HETE by fibrosarcoma cells.
1
18 110
19 1
20 16

About Keyvan Mahboubi

Keyvan Mahboubi is a scholar working on Immunology, Pharmacology and Pharmacology, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (8 papers), Inflammatory mediators and NSAID effects (7 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Biochemistry (140 citations), Immunology (331 citations) and Immunology and Allergy (70 citations). Keyvan Mahboubi has collaborated with scholars based in United States, Argentina and Germany. Frequent co-authors include David Fulton, Dario C. Altieri, Fengzhi Li, Daniel O’Connor, Andreas Papapetropoulos, Robert G. Kalb, William C. Sessa, Jordan S. Pober, John Quilley and J C McGiff. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026